MedPath

Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™

Phase 3
Completed
Conditions
Hepatitis B
Registration Number
NCT00445185
Lead Sponsor
Henogen
Brief Summary

The current extension study will assess the persistence of anti-HBs antibodies at Months 12, 24 and 36 after primary vaccination with Henogen's HBV vaccine or Fendrix™. This protocol posting deals with the objectives \& outcome measures of the extension phase at Months 12, 24 and 36. The objectives \& outcome measures of the primary phase are presented in a separate protocol posting (NCT00291941).

Detailed Description

Subjects who received complete full vaccination with Henogen HBV adjuvanted vaccine or Fendrix™ will participate in this persistence study for three long-term time points (12, 24 and 36 months after the first dose of primary vaccination). Blood sampling will be done at each time point to measure immune persistence.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Written informed consent obtained from the subject/ from the parent/ guardian of the subject.
  • Subjects who completed the full course of primary vaccination.
Exclusion Criteria
  • Immunosuppression caused by the administration of parenteral steroids or chemotherapy.
  • Any confirmed or suspected human immunodeficiency virus (HIV) infection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Anti-HBs antibody concentrationsMonths 12, 24 and 36.
Secondary Outcome Measures
NameTimeMethod
Quality of immune responseMonth 12, 24 and 36
SAEs retrospective reportingMonth 12, 24 and 36
RF-1 like antibody concentrations in the subset of subjects for whom this analysis was done at the primary study (HN014/HBV-001).Month 12, 24 and 36

Trial Locations

Locations (23)

O.L.Vrouwziekenhuis Aalst

🇧🇪

Aalst, Belgium

RHMS La Madeleine ATH

🇧🇪

Ath, Belgium

RHMS Clinique Louis Caty Baudour

🇧🇪

Baudour, Belgium

CHU Brugmann (site V Horta) Service de néphrologie

🇧🇪

Bruxelles, Belgium

ULB Hôpital Erasme Département de Néphrologie

🇧🇪

Bruxelles, Belgium

AZ -VUB Dienst Nefrologie

🇧🇪

Bruxelles, Belgium

Cliniques universitaires Saint Luc

🇧🇪

Bruxelles, Belgium

CHU Hôpital civil de

🇧🇪

Charleroi, Belgium

UZ Gent

🇧🇪

Gent, Belgium

CHU Tivoli

🇧🇪

La Louvière, Belgium

Scroll for more (13 remaining)
O.L.Vrouwziekenhuis Aalst
🇧🇪Aalst, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.